Prone Breast Radiotherapy Treatment Planning Observational Study (HUGProne)

December 18, 2022 updated by: Vincent Vinh-Hung

Retrospective Dosimetric Study of Prone Radiotherapy for Breast Cancer

The study purpose is to evaluate whether or not clinical characteristics of women with breast cancer can predict which position for radiation treatment, prone or supine, will be associated with a dosimetry gain. Dosimetry gain in this study means the lowest radiation dose to non-target organs (heart, lungs, contralateral breast), while giving the prescribed dose to tumor bed and ipsilateral breast.

Study Overview

Status

Active, not recruiting

Detailed Description

Retrospectively identify women who received curative radiation treatment after breast conserving cancer surgery, in whom simulation in prone and in supine position was performed. Compare the treatment plans for doses to targets and to non-target organs, according to clinical parameters of body mass index, size of breast, location of tumor and side. Furthermore, evaluate whether a single CT slide is enough or not to predict a dosimetry advantage.

Study Type

Observational

Enrollment (Anticipated)

280

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Geneva, Switzerland, 1205
        • Geneva University Hospitals

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

Consecutive patients addressed for adjuvant radiation treatment after breast conserving surgery for breast cancer, in whom simulation was done prone and supine.

Description

Inclusion Criteria:

  • Breast conserving surgery
  • Adjuvant radiation treatment
  • Simulation done prone and supine

Exclusion Criteria:

  • Simulation in only one position

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Only
  • Time Perspectives: Retrospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Prone and supine simulation
Women with breast cancer receiving simulation in prone and in supine position for adjuvant radiation treatment.
Treatment planning in the two positions.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Radiation dose to heart and lungs
Time Frame: 4 months
Computations of doses and verification of physics charts.
4 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Radiation dose to tumor bed and ipsilateral breast
Time Frame: 4 months
Computations of doses and verification of physics charts.
4 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Numbers of patients with dosimetry gain in prone position
Time Frame: 2 years
Evaluate the dosimetry gain in subgroups classified according to body mass index, size of breast, side and location of tumor.
2 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Vincent Vinh-Hung, MD, PhD, University of Genova

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2010

Primary Completion (Actual)

April 1, 2013

Study Completion (Anticipated)

December 1, 2023

Study Registration Dates

First Submitted

September 7, 2014

First Submitted That Met QC Criteria

September 9, 2014

First Posted (Estimate)

September 11, 2014

Study Record Updates

Last Update Posted (Actual)

December 21, 2022

Last Update Submitted That Met QC Criteria

December 18, 2022

Last Verified

December 1, 2022

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Breast Cancer Female

Clinical Trials on Prone and supine simulation

Subscribe